Christopher Goetz to Serotonin Receptor Agonists
This is a "connection" page, showing publications Christopher Goetz has written about Serotonin Receptor Agonists.
Connection Strength
0.070
-
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial. Mov Disord. 2007 Jan 15; 22(2):179-86.
Score: 0.070
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.